Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.26 (
GSK
)
6,788
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Microtubule arrays direct intracellular organization and define cellular polarity. Here, we show a novel function of
glycogen synthase kinase-3beta
(GSK-3beta) in the organization of microtubule arrays through the interaction with Bicaudal-D (BICD). BICD is known to form a complex with dynein-dynactin and to function in the intracellular vesicle trafficking. Our data revealed that
GSK
-3beta is required for the binding of BICD to dynein but not to dynactin. Knockdown of
GSK
-3beta or BICD reduced centrosomally focused microtubules and induced the mislocalization of centrosomal proteins. The unfocused microtubules in
GSK
-3beta knockdown cells were rescued by the expression of the dynein intermediate chain-BICD fusion protein. Microtubule regrowth assays showed that
GSK
-3beta and BICD are required for the anchoring of microtubules to the centrosome. These results imply that
GSK
-3beta may function in transporting centrosomal proteins to the centrosome by stabilizing the
BICD1
and dynein complex, resulting in the regulation of a focused microtubule organization.
...
PMID:GSK-3beta-regulated interaction of BICD with dynein is involved in microtubule anchorage at centrosome. 1713 49